Quarterly report pursuant to Section 13 or 15(d)

Balance Sheet Information - Accrued Expenses (Details)

v3.22.2.2
Balance Sheet Information - Accrued Expenses (Details) - USD ($)
Sep. 30, 2022
Dec. 31, 2021
Balance Sheet Information    
Executive Severance $ 666,784 $ 200,605
Payroll and Benefits 550,133 737,365
Professional Fees 442,605 194,425
Clinical Trials 124,858 168,785
Other 15,630 28,961
Total Accrued Expenses $ 1,800,010 $ 1,330,141